Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7

Sahil Adriouch1, Felix Scheuplein, Robert Bähring

  • 1Inserm U905, 76183, Rouen, France, sahil.adriouch@univ-rouen.fr.

Purinergic Signalling
|February 24, 2009
PubMed

Insights

Researchers characterized a P2X7 receptor mutant (R276A) with enhanced function. This gain-of-function mutant shows increased sensitivity to adenosine triphosphate (ATP), offering new avenues for studying inflammation and immune responses.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • The P2X7 purinoceptor is crucial for leukocyte activation, inflammasome assembly, IL-1beta release, and cell death.
  • Its role in inflammation and immune responses makes it a significant research target.

Purpose of the Study:

  • To functionally characterize a gain-of-function mutant (R276A) of the P2X7 purinoceptor.
  • To investigate the mutant's effects on membrane potential, calcium influx, and pore formation.

Main Methods:

  • Functional characterization of the P2X7 R276A mutant.
  • Analysis of membrane depolarization, calcium influx, and YO-PRO-1 dye uptake.
  • Assessment of receptor channel kinetics and ligand sensitivity.

Main Results:

  • The R276A mutant exhibits heightened sensitivity to low micromolar concentrations of adenosine triphosphate (ATP).
  • The mutant displays increased affinity for its ligands and slower channel closing kinetics.
  • These findings suggest evolutionary pressure maintains P2X7's low ATP sensitivity.

Conclusions:

  • The R276A P2X7 mutant provides a valuable tool for studying P2X7 receptor function in inflammatory and immune processes.
  • This mutant may facilitate the development of novel animal models to explore P2X7's role in disease.
  • Understanding P2X7 receptor dynamics is key to developing new therapeutic strategies for inflammatory conditions.

Related Concept Videos